People engaged in opioid agonist treatment as a counterpublic during the COVID‐19 pandemic in Australia: A qualitative study

INTRODUCTION: People receiving opioid agonist treatment (OAT) are at higher risk of comorbidities, poverty and discrimination, which Big Events like the COVID‐19 pandemic may exacerbate. The behaviours of people receiving OAT do not always align with normative behaviours as conceived by ruling insti...

Descripción completa

Detalles Bibliográficos
Autores principales: Conway, Anna, Treloar, Carla, Crawford, Sione, Grebely, Jason, Marshall, Alison D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538012/
https://www.ncbi.nlm.nih.gov/pubmed/36054577
http://dx.doi.org/10.1111/dar.13531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538012/
https://www.ncbi.nlm.nih.gov/pubmed/36054577
http://dx.doi.org/10.1111/dar.13531

Ejemplares similares